key: cord-1026937-t0jb00ni authors: Zhang, Shu; Zhou, Yongjie; Ge, Li-kun; Zeng, Lingyun; Liu, Zhengkui; Qian, Wei; Yang, Jiezhi; Zhou, Xin; Wei, Gao-Xia; Zhang, Xiangyang title: Interaction of Insomnia and Somatization with Post-Traumatic Stress Disorder in Pregnant Women During the COVID-19 Pandemic date: 2021-08-06 journal: Neuropsychiatr Dis Treat DOI: 10.2147/ndt.s310300 sha: c2e85d9242a0f94f3484d529fcf85f69eca5d247 doc_id: 1026937 cord_uid: t0jb00ni INTRODUCTION: Post-traumatic stress disorder (PTSD) has an adverse impact on the emotional health of prenatal maternal women and their offspring. During the Coronavirus Disease 2019 (COVID-19) pandemic, pregnant women are vulnerable to traumatic events and are prone to PTSD symptoms. The aim of the study was to explore the predictive effects of insomnia and somatization on PTSD in pregnant women by utilizing generalized additive model (GAM). MATERIALS AND METHODS: A total of 1638 pregnant women from three local cities in China underwent online survey on sleep quality, somatization, and PTSD symptoms tested by the Insomnia Severity Index (ISI), the subscale somatization of Symptom Checklist-90 (SCL-90-S) and the Checklist for DSM-5 (PCL-5), respectively. RESULTS: Insomnia was positively correlated with PTSD symptoms in pregnant women (p = 1.79×10(−5)). Interestingly, insomnia and somatization showed a complex non-primary linear interaction in predicting PTSD (p = 2.00×10(−16)). CONCLUSION: Our results suggest that insomnia is a prominent predictor of PTSD symptoms in pregnant women in the context of public emergencies. In addition, the effects of insomnia and somatization on PTSD symptoms are characterized by complex non-primary linear relationships. Currently, the Coronavirus Disease 2019 (COVID-19) pandemic has spread rapidly around the world, resulting in nearly 90.59 million confirmed cases and 1.93 million deaths (January 11, 2021). COVID-19 is regarded as a potential traumatic event, which is closely associated with the increase of PTSD symptoms in the general population. 1, 2, 4 In the context of this epidemic, many pregnant women gave up or lose the opportunity for regular antenatal check-ups because of the potential risk of infection, the need for home isolation and the lack of medical resources, which may increase the risk of developing PTSD. 3, 4 Prenatal PTSD not only affects the premature delivery and the lower birth weight of the offspring, 5 but causes their own mental disorders. 6, 7 Recently, a crosssectional survey conducted before and during the COVID-19, which showed that compared to pre-pandemic group, pregnant women of the pandemic group scored higher in the depression, anxiety and stress. 8 Another meta-analysis study showed that the overall prevalence of PTSD is 20%. 9 Therefore, in the context of COVID-19, it is of great significance to identify the risk factors for the prevention of PTSD in perinatal pregnant women. Insomnia has been considered as a symptom associated with primary mental health diseases. 10 Voitsidis et al 11 explored sleep difficulties during the COVID-19 pandemic in the Greek population and found that 37.6% of participants reported sleep problems, especially women. And the insomnia and PTSD detection detectable rate of pregnant women was 19% and 20% respectively. 9 Krakow et al 12 found that the severity of PTSD is closely associated with the quality of sleep. Insomnia occurs in 66-90% of people with PTSD. 13 Patients with more severe insomnia have more severe PTSD symptoms at the beginning of treatment of PTSD. A longitudinal study examined the severity of PTSD among postwar veterans who had experienced a 12-month war in Iraq, which indicated that insomnia in the 4th month was an important predictor of depression and PTSD symptoms in the 12th month. 14 Therefore, it is hypothesized that insomnia will predict PTSD symptoms in pregnant women during the 2019-nCoV epidemic. Further, PTSD patients are more likely to report somatization symptoms than patients with other mental disorders. 15 Somatization refers to the development of somatic symptoms without organic damage. 16 Elklit and Christiansen 16 suggested that even trauma victims without any serious injury may report more somatic symptoms than non-traumatic controls. A survey of 264 women attending the Department of Veterans Affairs primary care clinic showed that after controlling demographic variables, the status of veterans and other mood and anxiety disorders, PTSD was the best predictor of somatization. 17 Kounou et al 18 examined the relationship between posttraumatic response, PTSD symptoms, somatization, and quality of life in a sample of refugees for two years after the 2011 Ivory Coast socio-political crisis. The study found that somatization was a key feature of traumatic experiences, and targeting somatization combined with trauma-centered therapy improved the prognosis of PTSD patients. In view of the close association between PTSD and somatization, somatization may also be a potential factor that moderates the relationship between PTSD and insomnia in pregnant women. This study aimed to investigate the predictive effect of insomnia and somatic symptoms on PTSD. We hypothesized 1) with the COVID-19 epidemic progress, the symptoms of PTSD in pregnant women gradually increased; 2) there was an interaction between insomnia and somatization on PTSD symptoms; 3) both insomnia and somatization may predict the severity of PTSD symptoms. Because of the non-normal distribution of the current data, we used the Generalized Additive Model (GAM) to reduce risk related to the linear regression hypothesis. The main purpose of our findings may provide meaningful insights for early identification and intervention of PTSD in pregnant women. All participants came from three local cities: Wuhan, Beijing and other urban areas. The information was collected through an online survey from February 28, 2020 to April 9, 2020, which was run on a smartphone. Inclusion criteria included 1) perinatal pregnancy women >20 years old; 2) no history of major organic or somatization damage, and no diagnosis of any mental disorders such as schizophrenia, depression or anxiety. All these screening items related to mental health problems must be self-reported by filling in demographic information; 3) no medication within two weeks; 4) no history of drug, smoking or alcohol abuse. All participants signed the informed consent form. This study was approved by the Institutional Review Board of the Institute of Psychology, Chinese Academy of Sciences. It was performed in accordance with the ethical standards stipulated in the 1964 Declaration of Helsinki. The minimized sample size was estimated by previous literature about 15% PTSD on the COVID-19. 19 Finally, 1638 healthy pregnant women were included in this study. The average age was 30.20 years old, the average gestation period was 25.40 weeks, and the average pregnancy times and birth times were 1.64 and 1.18, respectively (Table 1) . Participants were asked to evaluate their feelings and symptoms based on the epidemic. When they responded to the questions of the rating scales, they must follow the introduction of measurement methods. We conducted a retrospective study, which data of PTSD symptom, insomnia symptom and somatization symptom were collected from all participants. In addition, socio-economic status was also involved as a covariate to control the potential confounding effect when examining the association between PTSD, insomnia, and somatization. The PTSD symptoms of each participant were assessed with the Chinese version of the PTSD Checklist for DSM-5 (PCL-5). It consists of 20 items, with scores ranging https://doi.org/10.2147/NDT.S310300 Neuropsychiatric Disease and Treatment 2021:17 2540 from "1 = never" to "5 = severe", including intrusive symptoms (symptom B), avoidance symptoms (symptom C), cognitive and negative emotional changes (symptom D), arousal and reactive changes (symptom E). This scale has good reliability and validity in Chinese local studies (Cronbach's α = 0.94). 20 The higher the score, the more severe the participants' PTSD symptoms. In order to prevent the overlap between items, a sleep-related item was removed in the statistical analysis (the 20th question in PCL-5: difficulty in falling asleep or very light sleep). The Insomnia Severity Index (ISI) is a short self-report tool with seven questions to measure participants' perceptions of both nocturnal and daytime insomnia symptoms (Cronbach's α = 0.90 for community sample; Cronbach's α = 0.91 for insomnia clinical sample). 21 Participants were asked to recall their sleep status during "the passed 2 weeks". The dimensions of the assessment are: severity of sleep onset, sleep maintenance, early morning awakening problems, sleep dissatisfaction, sleep disturbances that interfere with daytime functions, noticeability of sleep problems by others, and distress caused by sleep difficulties. 21 Using a 5-level score, from "0 = none" to "4 = extremely severe", the total score ranges from 0 to 28. The higher the score, the more severe the insomnia of the participants. The subscale somatization of Symptom Checklist-90 22 (SCL-90-S) was used to access participants' somatization symptoms, which includes 12 questions of SCL-90, such as item 1, 4, 12, 27, 40, 42, 49, 52, 53, 56, and 58. The subscale that indicates physical discomfort includes complaints of cardiovascular, gastrointestinal, respiratory, headaches, back pain, muscle soreness, and other somatic anxiety symptoms. The scale was rated as 5 levels (from 1 to 5) from "1 = none" to "5 = severe". The measurement of SES is calculated by education level, occupation and family property, where occupations are assigned based on Ganzeboom & Treiman model. 23 In order to calculate the comprehensive indicators of the participants' SES, SPSS for Mac 15.1 was used to conduct a factor analysis on education level, professional status, and family property. A principal factor with characteristic vector greater than 1 was obtained, which explains 55.16% of the variance. The factor load matrix used the coefficient of the primary factor 1 (Education level). The formula is as follows: SES = [0.803×Z(Education)+0.737×Z(Income)+0.681 ×Z(Occupation)]/0.552 First, the Shapiro-Wilk test of Skewness and Kurtosis was used to test the normal distribution of the collected data in SPSS for Mac 15.1. In view of the non-normal distribution of the current data, we used the "bam" function of the "mgcv" package in R to fit the GAM with controlling for the participants' age, 24 BMI, 25 SES, 26 weeks of pregnancy 27 (WP), times of pregnancy (TP) and times of births (TB) by putting them into the GAM equation in a linear fashion. If any data is missing, all data from that participant were deleted. In order to examine whether there are any differences between different pregnant periods, we divided all participants into three groups: first-trimester (pregnancy period ≤12 weeks), second-trimester (12